Ali Zarrinpar, MD, PhD - Research

Research at a glance

Top areas of exploration

Liver Transplantation , 45 publications
Graft Survival , 20 publications
Graft Rejection , 15 publications
Liver Neoplasms , 13 publications

Research activity

107 publications

4,162 citations

Why is this important?

Focus

Please see: https://surgery.med.ufl.edu/research/hepatobiliary-and-transplantation-laboratory/

Active clinical trials

NP-101 in Patients With Unresectable Hepatocellular Carcinoma Undergoing Y-90 Treatment

Surgical resection and liver transplantation are the primary curative treatments for hepatocellular carcinoma (HCC). However, many patients are ineligible for these treatments due to advanced disease, social factors, or limited availability of liver鈥�

Investigator: Ali Zarrinpar
Status: Accepting Candidates
Ages: 18 Years - 99 Years
Sexes: All

THINKER-NEXT

The Transplanting Hepatitis C Kidneys into Negative KidnEy Recipients [THINKER-NEXT] study will include adult kidney transplant candidates without hepatitis C virus (HCV) infection on the transplant waiting list who will consent to kidney鈥�

Investigator: Ali Zarrinpar
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

TGI

Investigator: Ali Zarrinpar
Status: Accepting Candidates

My publications

107 publications

2021

Machine Learning Applications in Solid Organ Transplantation and Related Complications.

Frontiers in immunology

鈥�

2021

Progress and challenges in diagnosis and treatment of rejection following liver transplantation.

Current opinion in organ transplantation

鈥�

2021

Racial Disparity in Liver Transplantation Listing.

Journal of the American College of Surgeons

鈥�

2021

Reassessment of the Hispanic Disparity: Hepatic Steatosis Is More Prevalent in Mexican Americans Than Other Hispanics.

Hepatology communications

鈥�

2021

Sex-Specific Differences in the Association Between Race/Ethnicity and NAFLD Among US Population.

Frontiers in medicine

鈥�

BOB体育